FINN Partners and Hyderus Unite to Create Major Global Health Communications and Policy Practice Serving Multinational Pharmaceutical, Vaccine, Device and Diagnostic Companies

Move Enables FINN to Address Pressing Health Priorities in Developed and Developing Nations and Expands Hyderus Global Service Capabilities and Client Offerings Hyderus Co-Founders Mark Chataway and Christopher Nial Join FINN Global Health Leaders Team, ....

Continue reading

AUM Biosciences, a Global Biotechnology Company Developing Precision Oncology Therapeutics, Announces Plans to Become a Public Company via Merger with Mountain Crest Acquisition Corp. V

The transaction reflects a pre-money equity value of $400 million for AUM Biosciences -Transaction is expected to provide $69 million of gross proceeds (assuming no redemptions by Mountain Crest stockholders) -Broad pipeline of drug candidates ....

Continue reading